Regulating LDL Cholesterol with LDLRAD2 (G401944)

Target Name: LDLRAD2

NCBI ID: G401944

LDLRAD2

Other Name(s): low density lipoprotein receptor class A domain containing 2 | Low-density lipoprotein receptor class A domain-containing protein 2 | Low density lipoprotein receptor class A domain containing 2 | LRAD2_HUMAN | low density lipoprotein receptor A domain containing 2

Regulating LDL Cholesterol with LDLRAD2

Low density lipoprotein receptor class A domain containing 2 (LDLRAD2) is a protein that is expressed in various tissues throughout the body, including the liver, heart, and muscle. It is a member of the LDL receptor family, which is a protein that is involved in the uptake and processing of low density lipoprotein (LDL) cholesterol by the liver.

LDLRAD2 is unique among its kind in that it is a non-functional receptor, meaning that it does not have the ability to bind to LDL cholesterol. Instead, it is involved in the regulation of LDL cholesterol levels by the liver. Specifically, LDL cholesterol is either taken up into the liver for processing and removed, or it is released back into the bloodstream.

The LDL receptor family is a crucial component of the immune system, as it helps to keep cholesterol levels in check. Cholesterol is a fatty substance that is found in the blood, and it is an essential component of cell membranes and hormones. However, too much cholesterol in the blood can cause a number of health problems, including the development of heart disease and stroke.

LDLRAD2 is an important protein that helps to regulate the levels of LDL cholesterol in the body. It is part of a signaling pathway that helps to control the levels of LDL cholesterol in the liver. This signaling pathway involves the interaction between LDL cholesterol and LDL receptor class A domain containing 2.

LDLRAD2 is a protein that is made up of 254 amino acids. It has a calculated molecular mass of 31.1 kDa. LDL cholesterol is a major component of the blood, and it is found in the bloodstream as well as in the liver. LDL cholesterol is made by the liver using cholesterol esters, which are created from dietary cholesterol.

LDLRAD2 is involved in the regulation of LDL cholesterol levels by the liver. It is part of a signaling pathway that helps to control the levels of LDL cholesterol in the liver. This signaling pathway involves the interaction between LDL cholesterol and LDL receptor class A domain containing 2.

LDLRAD2 helps to regulate the levels of LDL cholesterol in the liver by controlling the activity of enzymes that are involved in the metabolism of LDL cholesterol. Enzymes are proteins that catalyze chemical reactions in the body, and they are essential for the growth and development of all living organisms.

LDLRAD2 is also involved in the regulation of LDL cholesterol levels by the liver by controlling the activity of enzymes that are involved in the metabolism of LDL cholesterol. Enzymes are proteins that catalyze chemical reactions in the body and they are essential for the growth and development of all living organisms.

LDLRAD2 is a non-functional receptor, meaning that it does not have the ability to bind to LDL cholesterol. Instead, it is involved in the regulation of LDL cholesterol levels by the liver. Specifically, LDL cholesterol is either taken up into the liver for processing and removed, or it is released back into the bloodstream.

LDLRAD2 is expressed in various tissues throughout the body, including the liver, heart, and muscle. It is a member of the LDL receptor family, which is a protein that is involved in the uptake and processing of low density lipoprotein (LDL) cholesterol by the liver.

In conclusion, LDLRAD2 is a non-functional receptor that is involved in the regulation of LDL cholesterol levels by the liver. It is a crucial component of the immune system and helps to keep cholesterol levels in check. By controlling the activity of enzymes that are involved in the metabolism of LDL cholesterol, LDLRAD2 helps to regulate the levels of LDL cholesterol in the liver and keep it under control. As a drug target or biomarker, LDLRAD2 has the potential to be used to treat

Protein Name: Low Density Lipoprotein Receptor Class A Domain Containing 2

The "LDLRAD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LDLRAD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets